ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma. (linkinghub.elsevier.com)

Authors: Song C … Wang H Journal: Drug Resistance Updates Published: 2026-07-31 DOI: https://doi.org/10.1016/j.drup.2026.101466